MyJournals Home  

RSS FeedsPharmaceuticals, Vol. 14, Pages 934: Manufacturing Bacteriophages (Part 1 of 2): Cell Line Development, Upstream, and Downstream Considerations (Pharmaceuticals)

 
 

17 september 2021 13:30:42

 
Pharmaceuticals, Vol. 14, Pages 934: Manufacturing Bacteriophages (Part 1 of 2): Cell Line Development, Upstream, and Downstream Considerations (Pharmaceuticals)
 


Within this first part of the two-part series on phage manufacturing, we will give an overview of the process leading to bacteriophages as a drug substance, before covering the formulation into a drug product in the second part. The principal goal is to provide the reader with a comprehensive framework of the challenges and opportunities that present themselves when developing manufacturing processes for bacteriophage-based products. We will examine cell line development for manufacture, upstream and downstream processes, while also covering the additional opportunities that engineered bacteriophages present.


 
161 viewsCategory: Medicine, Pharmacology
 
Pharmaceuticals, Vol. 14, Pages 933: Neuropsychiatric Disorders and COVID-19: What We Know So Far (Pharmaceuticals)
Pharmaceuticals, Vol. 14, Pages 935: The Metabolomic Approach Reveals the Alteration in Human Serum and Cerebrospinal Fluid Composition in Parkinson`s Disease Patients (Pharmaceuticals)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten